Small Molecule CDMO Market

Future Market Insights

Key Insight

The small molecule CDMO mark is projected to grow from USD 76.1 billion in 2025 to USD 145.5 billion by 2035, at a CAGR of 6.7%. Active Pharmaceutical Ingredients (API) will dominate with a 61.8% market share, while innovators will lead the drug type segment with a 55.0% share.

October 09, 2025

Anurag Sharma

250 Pages

Cite this Report

Small Molecule CDMO Market

https://www.futuremarketinsights.com/reports/small-molecule-cdmo-market

License

Buy Now

Summary ToC Companies

Key Players

Aurigene Pharmaceutical Services Ltd
Bellen Chemistry
Cambrex Corporation
Catalent Inc
CordenPharma International
Eurofins Scientific
Lonza
Recipharm AB
Siegfried Holding AG
Thermo Fisher Scientific Inc.

Methodology

Member of

Greater New York Chamber of Commerce

Recognized by

Awarded by

SILVER STEVIE® WINNER

Asia Pacific Stevie Awards - 2023

BRONZE STEVIE® Award

20th annual IBAs

Quick Contact

Chat on Whatsapp + 44 20 3769 9709 + 1 347 918 3531 Contact By Email

Get Free Sample PDF

Small Molecule CDMO Market

Key Players

Similar Industry Reports